APA aipamena

Marconcini, R., Galli, L., Antonuzzo, A., Bursi, S., Roncella, C., Fontanini, G., . . . Falcone, A. (2017). Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months. Exp Hematol Oncol.

Chicago Style aipamena

Marconcini, Riccardo, Luca Galli, Andrea Antonuzzo, Simona Bursi, Claudia Roncella, Gabriella Fontanini, Elisa Sensi, and Alfredo Falcone. "Metastatic BRAF K601E-mutated Melanoma Reaches Complete Response to MEK Inhibitor Trametinib Administered for Over 36 months." Exp Hematol Oncol 2017.

MLA aipamena

Marconcini, Riccardo, et al. "Metastatic BRAF K601E-mutated Melanoma Reaches Complete Response to MEK Inhibitor Trametinib Administered for Over 36 months." Exp Hematol Oncol 2017.